Advantages of ion-exchange chromatography for oligonucleotide analysis

Bioanalysis

Volumn 3, Issue 10, 2011, Pages 1109-1120

  Cook, Ken ^a   Thayer, Jim ^a  

^a DIONEX CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; BIOPOLYMER; ESTER DERIVATIVE; OLIGONUCLEOTIDE; PHOSPHODIESTER; PHOSPHOROTHIOIC ACID; UNCLASSIFIED DRUG;

ANION EXCHANGE CHROMATOGRAPHY; DIASTEREOISOMER; DRUG FORMULATION; DRUG IMPURITY; DRUG STABILITY; EXTRACTION; GEL PERMEATION CHROMATOGRAPHY; ION EXCHANGE CHROMATOGRAPHY; LINKAGE ANALYSIS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NUCLEIC ACID ANALYSIS; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; REVERSED PHASE LIQUID CHROMATOGRAPHY; REVIEW; RNA INTERFERENCE; SEQUENCE ANALYSIS; TEMPERATURE SENSITIVITY;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, ION EXCHANGE; MASS SPECTROMETRY; OLIGONUCLEOTIDES; PHOSPHATES; STEREOISOMERISM;

EID: 79956275808     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.11.66     Document Type: Review

References (52)

1. Schena M, Shalon D, Davis RW, Brown PO. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 270 (5235), 467-470 (1995).
2. Pollack JR, Perou CM, Alizadeh AA, et al. Genome-wide analysis of DNA copy-number changes using cDNA microarrays. Nat. Genet. 23(1), 41-46 (1999). (Pubitemid 29418785)
3. Bammler T, Beyer RP. Consortium, Members of the Toxicogenomics Research. Standardizing global gene expression analysis between laboratories and across platforms. Nat. Methods 2(5), 351-356 (2005).
4. Saiki RK, Gelfand DH, Stoffel S, et al. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239(4839), 487-491 (1988). (Pubitemid 18084310)
5. Pavlov AR, Pavlova NV, Kozyavkin SA, Slesarev AI. Recent developments in the optimization of thermostable DNA polymerases for efficient applications. Trends Biotechnol. 22(5), 253-260 (2004). (Pubitemid 38515743)
6. Beilhartz GL, Götte M. HIV-1 Ribonuclease H: structure, catalytic mechanism and inhibitors. Viruses 1(2), 900-926 (2010).
7. Klarmann GJ, Hawkins ME, Le Grice SF. Uncovering the complexities of retroviral ribonuclease H reveals its potential as a therapeutic target. AIDS Rev. 4(4), 183-194 (2002). (Pubitemid 36104230)
8. Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75(5), 843-854 (1993). (Pubitemid 24014542)
9. Lim LP, Lau NC, Garrett-Engele P, et al. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 433 (7027), 769-773 (2005). (Pubitemid 40292988)
10. Poy MN, Eliasson L, Krutzfeldt J, et al. A pancreatic islet-specific microRNA regulates insulin secretion. Nature 432(7014), 226-230 (2004). (Pubitemid 39545853)
11. Wilfred BR, Wang WX, Nelson PT. Energizing miRNA research: a review of the role of miRNAs in lipid metabolism, with a prediction that miR-103/107 regulates human metabolic pathways. Mol. Genet. Metab. 91(3), 209-217 (2007). (Pubitemid 46819124)
12. Weiss B. Antisense Oligodeoxynucleotides and Antisense RNA: Novel Pharmacological and Therapeutic Agents. CRC Press, Boca Raton, FL, USA (1997).
13. Weiss B, Davidkova G, Zhou L-W. Antisense RNA gene therapy for studying and modulating biological processes. Cell. Mol. Life Sci. 55, 334-358 (1999). (Pubitemid 29178878)
14. Rana TM. Illuminating the silence: understanding the structure and function of small RNAs. Nat. Rev. Molec. Cell Biol. 8(1), 23 (2007).
15. Hamilton A, Baulcombe D. A species of small antisense RNA in posttranscriptional gene silencing in plants. Science 286 (5441), 950-952 (1999).
16. Elbashir S, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411(6836), 494-988 (2001).
17. Alekseev OM, Richardson RT, Alekseev O, ORand MG. Analysis of gene expression profiles in HeLa cells in response to overexpression or siRNA-mediated depletion of NASP. Reprod. Biol. Endocrinol. 7, 45 (2009).
18. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 136(2), 215-233 (2009).
19. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116(2), 281-297 (2004).
20. Bentwich I, Avniel A, Karov Y, et al. Identification of hundreds of conserved and nonconserved human microRNAs. Nat. Genet. 37(7), 766-770 (2005). (Pubitemid 41754896)
21. Friedman RC, Farh KK, Burge CB, Bartel DP. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 19(1), 92-105 (2009).
22. Bertone P, Stolc V, Royce TE, et al. Global identification of human transcribed sequences with genome tiling arrays. Science 306(5705), 2242-2246 (2004). (Pubitemid 40024458)
23. Kuhn DE, Martin MM, Feldman DS, Terry AV, Nuovo GJ, Elton TS. Experimental validation of miRNA targets. Methods 44(1), 47-54 (2008). (Pubitemid 350297983)
24. Tansey B. Macular degeneration treatment interferes with RNA messages. San Francisco Chronicle. 11 August 2006. Also found at: www.sfgate.com/cgi-bin/ article.cgi?f=/c/a/2006/08/11/ BUGPNKFU6T1.DTL
25. Trang P, Weidhaas JB, Slack FJ. MicroRNAs as potential cancer therapeutics. Oncogene 27(Suppl. 2), S52-S57 (2008).
26. Li C, Feng Y, Coukos G, Zhang L. Therapeutic microRNA strategies in human cancer. AAPS Journal 11(4), 747-757 (2009).
27. Ellington AD, Szostak JW. In vitro selection of RNA molecules that bind specific ligands. Nature 346 (6287), 818-822 (1990).
28. Ng EW, Shima DT, Calias P, Cunningham ET, Guyer DR, Adamis AP. Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease. Nat. Rev. Drug Discov. 5 (2), 123-132 (2006).
29. Sullenger BA, Gilboa E. Emerging clinical applications of RNA. Nature 418(6894), 252-258 (2002). (Pubitemid 34773785)
30. Cummins LL, Winniman M, Gaus HJ. Phosphorothioate oligonucleotide metabolism: charcaterization of the N+-mer by CE and HHPLC-ESI/MS. Bioorg. Med. Chem. Lett. 7, 1225-1230 (1997).
31. Gaus HJ, Owens SR, Winniman M, Cooper S, Cummins L. On-line HPLC electrospray mass spectrometry of phosphorothioate oligonucleotide metabolites. Anal. Chem. 69, 313-319 (1997).
32. Apffel A, Chakel JA, Fischer S, Lichtenwalter K, Hancock WS. New procedure for the use ofhigh-performance liquid chromatography-electrospray ionization mass spectrometry for the analysis of nucleotides and oligonucleotides. J. Chromatogr. A 777, 3-21 (1997). (Pubitemid 27353323)
33. Fountain KJ, Gilar M, Gebler JC. Analysis of native and chemically modified oligonucleotides by tandem ion-pair reversed-phase high-performance liquid chromatography/electrospray ionization mass spectrometry. Rapid Commun. Mass Spectrom. 17(7), 646-653 (2003). (Pubitemid 36373163)
34. Huber CG, Krajete A. Analysis of nucleic acids by capillary ion-pair reversed-phase HPLC coupled to negative-ion electrospray ionization mass spectrometry. Anal. Chem. 71(17), 3730-3739 (1999).
35. Wei X, Dai G, Liu Z, et al. Metabolism of GTI-2040, a phosphorothioate oligonucleotide antisense, using ion-pair reversed phase high performance liquid chromatography (HPLC) coupled with electrospray ion-trap mass spectrometry. AAPS J. 8(4) 84 (2006).
36. Thayer JR, Puri N, Burnett C, Hail ME, Rao S. Identification of RNA linkage isomers by anion-exchange purification with ESI-MS of automatically desalted phosphodiesterase-II digests. Analytical Biochemistry 399, 110-117 (2009).
37. Thayer JR, McCormick RM, Avdalovic N. High-resolution nucleic acid separations by high-performance liquid chromatography. In: Methods in Enzymology. Karger B, Hanckock W (Eds). Academic Press 271, 147-174 (1996).
38. Bergot BJ, Egan W. Separation of synthetic oligodeoxynucleotides from their oxygenated (phosphodiester) defect species by strong-anion-exchange high performance liquid chromatography J. Chromatogr. 599, 35 (1992).
39. Sproat BS, Rupp T, Menhardt N, Keane D, Beijer B. Fast and simple purification of chemically modified hammerhead ribozymes using a lipophilic capture tag. Nucl. Acids Res. 27, 1950-1955 (1999). (Pubitemid 29209640)
40. Murray JB, Dunham CM, Scott WG. A pH-dependent conformational change, rather than the chemical step, appears to be rate-limiting in the hammerhead ribozyme cleavage reaction. J. Mol. Biol. 315, 121-130 (2002). (Pubitemid 34722116)
41. Eon-Duval A, Burke G. Purification of pharmaceutical-grade plasmid DNA by anion-exchange chromatography in and RNAse-free process. J. Chromatogr. B 804, 327-335 (2004). (Pubitemid 38481708)
42. Xu Q, Musier-Forsyth K, Hammer RP, Barany G. Use of 1,2,4-Dithiazolidine- 3,5-dione (DtsNH) and 3-Ethoxy-1,2,4-dithiazoline-5-one (EDITH) for synthesis of phosphorothioate-containing oligodeoxyribonucleotides. Nucl. Acids Res. 24, 1602-1607 (1996). (Pubitemid 26137915)
43. Fearon KL, Stults JT, Bergot BJ, Christensen LM, Raible AM. Investigation of the n-1 impurity in phosphorothioate oligodeoxynucleotides synthesized by the solid-phase b-cyanoethyl phosphoramidite method using stepwise sulfurization. Nucl. Acids Res. 23, 2754-2761 (1995).
44. Grant GPG, Popova A, Qin PZ. Diastereomer characterizations of nitroxide-labeled nucleic acids. Biochem. Biophys. Res. Commun. 371, 451-455 (2008).
45. Thayer JR, Wu Y, Hansen E, Angelino MD, Rao S. Separation of oligonucleotide phosphorothioate diastereoisomers by pellicular anion-exchange chromatography. J. Chromatogr. B 878, 933-941 (2011).
46. Pham JW, Radhakrishnan I, Sontheimer EJ. Thermodynamic and structural characterization of 2′-nitrogen-modified RNA duplexes. Nucl. Acids Res. 32, 3446-3455 (2004). (Pubitemid 39117461)
47. Thayer JR, Murugaiah V, Wu Y. Purity analysis and impurities determination by AEX-HPLC. In: Handbook of Analysis of Oligonucleotides and Related Products. Bonilla J, Srivatsa GS (Eds). CRC press (2011).
48. Thayer JR, Barreto V, Rao S, Pohl C. Control of oligonucleotide retention on a pH-stabilized anion exchange column. Anal. Bioch. 338, 39-47 (2005). (Pubitemid 40228896)
49. Thayer JR, Rao S, Puri N. Detection of aberrant 2′-5′ linkages in RNA by anion exchange. In: Current Protocols in Nucleic Acid Chemistry. Beaucage S (Ed.). Wiley Interscience, John Wiley and Sons (2008).
50. Thayer JR, Rao S, Puri N, Burnett CA, Young M. Identification of aberrant 2′-5′ RNA linkage isomers by pellicular anion-exchange chromatography. Anal. Bioch. 361, 132-139 (2007). (Pubitemid 46039803)
51. Bourque AJ, Cohen AS. Quantitative analysis of phosphorothioate oligonucleotides in biological fluids using direct injection fast anion-exchange chromatography and capillary gel electrophoresis. J. Chromatogr. B 662, 343-349 (1994). (Pubitemid 24377233)
52. Chen S-H, Qian M, Brennan JM, Gallo JM. Determination of antisense phosphorothioate oligonucleotides and catabolites in biological fluids and tissue extracts using anion-exchange high-performance liquid chromatography and capillary gel electrophoresis. J. Chromatogr. B 692, 43-51 (1997). (Pubitemid 27208465)